JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Flt3L in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal CancerMetastatic Cancer
- First Posted Date
- 2004-08-04
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Duke University
- Registration Number
- NCT00003431
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors
- Conditions
- Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 6
- Registration Number
- NCT00002754
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2013-02-18
- Lead Sponsor
- Duke University
- Target Recruit Count
- 6
- Registration Number
- NCT00002753
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
- Conditions
- Metastatic Cancer
- First Posted Date
- 2004-07-01
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 6
- Registration Number
- NCT00002751
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-03-07
- Lead Sponsor
- Duke University
- Registration Number
- NCT00003435
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Melphalan in Patients With Neoplastic Meningitis
- Conditions
- Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemiaLymphomaOvarian Cancer
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 6
- Registration Number
- NCT00002750
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-05-20
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 17
- Registration Number
- NCT00004211
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 36
- Registration Number
- NCT00002988
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 24
- Registration Number
- NCT00003020
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
- Conditions
- Brain and Central Nervous System TumorsLymphoma
- First Posted Date
- 2004-05-04
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Duke University
- Target Recruit Count
- 19
- Registration Number
- NCT00006342
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States